×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Morrison Briggs

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorAug 09, 2023Option Exercise$8.7752,855463,53870,691Aug 10, 2023, 06:50 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorAug 09, 2023Sale$18.2752,855965,40217,836Aug 10, 2023, 06:50 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJul 10, 2023Option Exercise$8.7752,855463,53870,691Jul 11, 2023, 09:23 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJul 10, 2023Sale$20.4052,8551,078,06817,836Jul 11, 2023, 09:23 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJun 09, 2023Sale$21.1852,8551,119,42146,109Jun 09, 2023, 05:32 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorJun 09, 2023Option Exercise$7.6652,855404,78770,691Jun 09, 2023, 05:32 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorMay 09, 2023Option Exercise$6.3852,855337,21570,691May 10, 2023, 04:11 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorMay 09, 2023Sale$21.4152,8551,131,47817,836May 10, 2023, 04:11 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorApr 10, 2023Sale$19.5352,8551,032,23717,836Apr 12, 2023, 04:03 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsDirectorApr 10, 2023Option Exercise$6.3852,855337,21570,691Apr 12, 2023, 04:03 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DMar 13, 2023Option Exercise$6.3852,854337,20970,690Mar 14, 2023, 04:42 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DMar 13, 2023Sale$22.5352,8541,190,67417,836Mar 14, 2023, 04:42 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DFeb 06, 2023Option Exercise$6.3852,854337,20970,690Feb 08, 2023, 04:49 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DFeb 06, 2023Sale$26.8352,8541,417,90917,836Feb 08, 2023, 04:49 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 20, 2022Sale$23.2559,6491,387,01217,836Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 19, 2022Option Exercise$10.90114,3391,246,295132,175Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 19, 2022Sale$23.03114,3392,633,04417,836Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 20, 2022Option Exercise$10.9059,649650,17477,485Sep 21, 2022, 04:18 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 16, 2022Option Exercise$8.77125,0001,096,22689,802Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 16, 2022Sale$23.22125,0002,902,43717,836Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 14, 2022Option Exercise$7.2087,645631,044105,481Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 14, 2022Sale$23.8087,6452,085,85517,836Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 15, 2022Option Exercise$7.2066,775480,78084,611Sep 16, 2022, 05:34 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DSep 15, 2022Sale$24.2066,7751,616,03517,836Sep 16, 2022, 05:34 PM
ARVNARVINAS, INC.Morrison BriggsDirectorApr 14, 2022Sale$66.4420,9601,392,61637,834Apr 18, 2022, 09:00 PM
ARVNARVINAS, INC.Morrison BriggsDirectorApr 14, 2022Option Exercise$16.0016,188259,00840,936Apr 18, 2022, 09:00 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 01, 2022Option Exercise$7.2070,545507,92488,381Apr 13, 2022, 04:09 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 04, 2022Option Exercise$7.203,12822,52220,964Apr 13, 2022, 04:09 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 01, 2022Sale$17.45101,0451,763,51542,336Apr 05, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 04, 2022Option Exercise$10.903,12834,09520,964Apr 05, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 04, 2022Sale$18.293,12857,22017,836Apr 05, 2022, 04:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsPresident, Head of R&DApr 01, 2022Option Exercise$10.9070,545768,94088,381Apr 05, 2022, 04:05 PM
ARVNARVINAS, INC.Morrison BriggsDirectorJan 14, 2022Option Exercise$16.0016,188259,00845,708Jan 19, 2022, 09:00 PM
ARVNARVINAS, INC.Morrison BriggsDirectorJan 14, 2022Sale$65.5520,9601,374,02135,789Jan 19, 2022, 09:00 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerDec 17, 2021Option Exercise$10.9035,156383,20083,492Dec 20, 2021, 06:44 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerDec 17, 2021Sale$20.0035,156703,12048,336Dec 20, 2021, 06:44 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 17, 2021Option Exercise$7.2070,262505,886118,598Sep 21, 2021, 04:35 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 17, 2021Sale$20.0770,2621,410,01848,336Sep 21, 2021, 04:35 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 20, 2021Option Exercise$7.205036048,386Sep 21, 2021, 04:35 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerSep 20, 2021Sale$20.00501,00048,336Sep 21, 2021, 04:35 PM
CDAKCodiak BioSciences, Inc.Morrison BriggsDirectorFeb 17, 2021Buy$21.004,76199,9814,761Feb 17, 2021, 06:05 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerFeb 08, 2021Option Exercise$7.2035,156253,12383,492Feb 10, 2021, 04:23 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerFeb 08, 2021Sale$20.5535,156722,40348,336Feb 10, 2021, 04:23 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerJan 31, 2021Option Exercise$12.001,77121,25248,336Feb 05, 2021, 04:21 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 09, 2020Sale$20.0462,9381,261,26546,565Nov 12, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 10, 2020Option Exercise$7.2017,466125,75564,031Nov 12, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 10, 2020Sale$20.0617,466350,31246,565Nov 12, 2020, 05:55 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerNov 09, 2020Option Exercise$7.2062,938453,154109,503Nov 12, 2020, 05:55 PM
RPTXRepare Therapeutics Inc.Morrison BriggsDirectorJun 23, 2020Buy$20.004,80096,0004,800Jun 25, 2020, 05:57 PM
ARVNARVINAS, INC.Morrison BriggsDirectorMar 24, 2020Buy$38.182,50095,45029,520Mar 25, 2020, 04:45 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerFeb 04, 2020Buy$8.0012,500100,00043,900Feb 05, 2020, 04:07 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerOct 10, 2019Buy$5.4011,00059,40031,400Oct 11, 2019, 06:33 AM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerMay 09, 2019Buy$7.5513,20099,72613,200May 13, 2019, 04:11 PM
SNDXSyndax Pharmaceuticals IncMorrison BriggsChief Executive OfficerMay 13, 2019Buy$7.297,20052,51720,400May 13, 2019, 04:11 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe